CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’Adulte | Zendy

Christophe Bonnet | Zendy; Georges Fillet | Zendy; Nicolas Mounier | Zendy; G. Ganem | Zendy; Thierry Jo Molina | Zendy; Catherine Thiéblemont | Zendy; Christophe Fermé | Zendy; Bruno Quesnel | Zendy; C. Martin | Zendy; Christian Gisselbrecht | Zendy; Hervé Tilly | Zendy; Félix Reyes | Zendy

Open Access

CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’Adulte

Author(s) -

Christophe Bonnet,

Georges Fillet,

Nicolas Mounier,

G. Ganem,

Thierry Jo Molina,

Catherine Thiéblemont,

Christophe Fermé,

Bruno Quesnel,

C. Martin,

Christian Gisselbrecht,

Hervé Tilly,

Félix Reyes

Publication year - 2007

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2006.07.0722

Subject(s) - medicine , vincristine , chop , radiation therapy , international prognostic index , prednisone , chemotherapy , lymphoma , oncology , stage (stratigraphy) , aggressive lymphoma , chemoradiotherapy , adverse effect , surgery , cyclophosphamide , gastroenterology , rituximab , paleontology , biology

Chemoradiotherapy has been considered standard treatment for patients with limited-stage aggressive lymphoma on the basis of trials conducted before the introduction of the International Prognostic Index. To evaluate this approach in elderly patients with low-risk localized lymphoma, we conducted a trial comparing chemoradiotherapy with chemotherapy alone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research